(Q47932523)

6 February 2018

title

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety (English)

1 reference

6 February 2018

0 references

1 reference

Sho Konno

1

1 reference

6 February 2018

Pillaiyar Thanigaimalai

2

1 reference

6 February 2018

Takehito Yamamoto

3

1 reference

6 February 2018

Kiyohiko Nakada

4

1 reference

6 February 2018

Rie Kakiuchi

5

1 reference

6 February 2018

Kentaro Takayama

6

1 reference

6 February 2018

Yuri Yamazaki

7

1 reference

6 February 2018

Fumika Yakushiji

8

1 reference

6 February 2018

Kenichi Akaji

9

1 reference

6 February 2018

Yoshiaki Kiso

10

1 reference

6 February 2018

Yuko Kawasaki

11

1 reference

6 February 2018

Shen-En Chen

12

1 reference

6 February 2018

Ernesto Freire

13

1 reference

6 February 2018

Yoshio Hayashi

14

1 reference

6 February 2018

language of work or name

English

0 references

publication date

24 November 2012

1 reference

6 February 2018

Bioorganic & Medicinal Chemistry

published in

1 reference

6 February 2018

volume

21

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

412-424

1 reference

6 February 2018

Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

cites work

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro

1 reference

12 December 2020

Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements

1 reference

12 December 2020

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

1 reference

12 December 2020

Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant

1 reference

12 December 2020

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease

1 reference

12 December 2020

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors

1 reference

12 December 2020

Design of wide-spectrum inhibitors targeting coronavirus main proteases

1 reference

12 December 2020

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

1 reference

12 December 2020

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

12 December 2020

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

1 reference

12 December 2020

Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors

1 reference

12 December 2020

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease

1 reference

12 December 2020

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.

1 reference

12 December 2020

Mechanisms and enzymes involved in SARS coronavirus genome expression

1 reference

12 December 2020

Long-range cooperative interactions modulate dimerization in SARS 3CLpro.

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

1 reference

12 December 2020

Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro

1 reference

12 December 2020

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors

1 reference

12 December 2020

10.1016/J.BMC.2012.11.017

Identifiers

DOI

1 reference

6 February 2018

0 references

0 references

1 reference

6 February 2018